Category Archives: Pediatrics

Pediatrics

Pediatric obesity during COVID-19: the role of neighborhood social vulnerability and collective efficacy | International … – Nature.com

Boutari C, Mantzoros CS. A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on. Metabolism. 2022;133:155217. https://doi.org/10.1016/J.METABOL.2022.155217.

Restrepo BJ. Obesity prevalence Among U.S. adults during the COVID-19 pandemic. Am J Prev Med. 2022;63:1026.

Article PubMed PubMed Central Google Scholar

Woolford SJ, Sidell M, Li X, Else V, Young DR, Resnicow K, et al. Changes in body mass index among children and adolescents during the COVID-19 pandemic. JAMA. 2021;326:14346.

Article CAS PubMed PubMed Central Google Scholar

Jenssen BP, Kelly MK, Powell M, Bouchelle Z, Mayne SL, Fiks AG. COVID-19 and changes in child obesity. Pediatrics. 2021;147:e2021050123. https://doi.org/10.1542/PEDS.2021-050123.

Lange SJ, Kompaniyets L, Freedman DS, Kraus EM, Porter R, Blanck HM, et al. Longitudinal trends in body mass index before and during the COVID-19 pandemic among persons aged 219 years United States, 20182020. MMWR Morb Mortal Wkly Rep. 2021;70:127883.

Article CAS PubMed PubMed Central Google Scholar

Daniels KM, Schinasi LH, Auchincloss AH, Forrest CB, Diez Roux AV. The built and social neighborhood environment and child obesity: a systematic review of longitudinal studies. Prev Med (Baltim). 2021;153:106790.

Article Google Scholar

Dunton GF, Do B, Wang SD. Early effects of the COVID-19 pandemic on physical activity and sedentary behavior in children living in the U.S. BMC Public Health. 2020;20:1351. https://doi.org/10.1186/S12889-020-09429-3.

Obesity, Race/Ethnicity, and COVID-19 | Overweight & Obesity | CDC. https://www.cdc.gov/obesity/data/obesity-and-covid-19.html. Accessed 1 May 2022.

Kondo MC, Felker-Kantor E, Wu K, Gustat J, Morrison CN, Richardson L, et al. Stress and distress during the COVID-19 pandemic: the role of neighborhood context. Int J Environ Res Public Health. 2022;19:2779. https://doi.org/10.3390/IJERPH19052779.

Zenic N, Taiar R, Gilic B, Blazevic M, Maric D, Pojskic H, et al. Levels and changes of physical activity in adolescents during the COVID-19 pandemic: contextualizing urban vs. rural living environment. Appl Sci. 2020;10:3997.

Article CAS Google Scholar

Mitra R, Moore SA, Gillespie M, Faulkner G, Vanderloo LM, Chulak-Bozzer T, et al. Healthy movement behaviours in children and youth during the COVID-19 pandemic: exploring the role of the neighbourhood environment. Health Place. 2020;65:102418.

Article PubMed PubMed Central Google Scholar

Winston P. Office of Human Services Policy USD of Health & HS. COVID-19 and economic opportunity: unequal effects on economic need and program response. 2021 https://aspe.hhs.gov/sites/default/files/private/pdf/265391/covid-19-human-service-response-brief.pdf. Accessed 19 Nov 2023.

Karmakar M, Lantz PM, Tipirneni R. Association of social and demographic factors with COVID-19 incidence and death rates in the US. JAMA Netw Open. 2021;4:e2036462. https://doi.org/10.1001/JAMANETWORKOPEN.2020.36462.

Khanijahani A, Iezadi S, Gholipour K, Azami-Aghdash S, Naghibi D. A systematic review of racial/ethnic and socioeconomic disparities in COVID-19. Int J Equity Health. 2021;20:130.

Article Google Scholar

CDC Community Profile Philadelphia, PA Communities Putting Prevention to Work. https://www.cdc.gov/nccdphp/dch/programs/communitiesputtingpreventiontowork/communities/profiles/both-pa_philadelphia.htm. Accessed 21 Jun 2023.

Bjornstrom EES. An examination of the relationship between neighborhood income inequality, social resources, and obesity in Los Angeles county. Am J Health Promot. 2011;26:10915.

Article PubMed Google Scholar

Kranjac AW, Kranjac D, Kain ZN, Ehwerhemuepha L, Jenkins BN. Obesity heterogeneity by neighborhood context in a largely Latinx sample. J Racial Ethn Health Disparities 2023. https://doi.org/10.1007/S40615-023-01578-6.

Sharifi M, Sequist TD, Rifas-Shiman SL, Melly SJ, Duncan DT, Horan CM, et al. The role of neighborhood characteristics and the built environment in understanding racial/ethnic disparities in childhood obesity. Prev Med (Baltim). 2016;91:1039.

Article Google Scholar

CDC. Division of Nutrition, Physical Activity, and Obesity. Modified z-scores in the CDC growth charts. 2022. https://www.cdc.gov/nccdphp/dnpa/growthcharts/resources/biv-cutoffs.pdf. Accessed 17 Aug 2022.

The US CDC 2000 Growth Charts. Defining childhood obesity. 19 Jul 2016. https://www.cdc.gov/obesity/childhood/defining.html.

Mayne SL, Hannan C, Davis M, Young JF, Kelly MK, Powell M, et al. COVID-19 and adolescent depression and suicide risk screening outcomes. Pediatrics. 2021;148:e2021051507. https://doi.org/10.1542/PEDS.2021-051507.

CDC: Department of Health and Human Services. Dear Colleague letter- DSTDP Lab and Drug Shortages. https://www.cdc.gov/std/dstdp/dcl/DCL-Diagnostic-Test-Shortage.pdf. Accessed 2 Jun 2022.

Yu CY, Woo A, Emrich CT, Wang B. Social Vulnerability Index and obesity: an empirical study in the US. Cities. 2020;97:102531.

Article Google Scholar

Aris IM, Perng W, Dabelea D, Padula AM, Alshawabkeh A, Vlez-Vega CM, et al. Associations of neighborhood opportunity and social vulnerability with trajectories of childhood body mass index and obesity among US children. JAMA Netw Open. 2022;5:E2247957.

Article PubMed PubMed Central Google Scholar

Khazanchi R, Beiter ER, Gondi S, Beckman AL, Bilinski A, Ganguli I. County-level association of social vulnerability with COVID-19 cases and deaths in the USA. J Gen Intern Med. 2020;35:27847.

Article PubMed PubMed Central Google Scholar

Krieger N, Waterman PD, Spasojevic J, Li W, Maduro G, Van Wye G. Public health monitoring of privilege and deprivation with the index of concentration at the extremes. Am J Public Health. 2016;106:256.

Article PubMed PubMed Central Google Scholar

Centers for Disease Control and Prevention/Agency for Toxic Substances and Disease Registry/Geospatial Research, Analysis, and Services Program. CDC/ATSDR Social Vulnerability Index Database. https://www.atsdr.cdc.gov/placeandhealth/svi/documentation/pdf/SVI2018Documentation_01192022_1.pdf. Accessed 7 Jun 2022.

diversitydatakids.org. 2022. Child Opportunity Index 2.0 database. https://data.diversitydatakids.org/dataset/coi20-child-opportunity-index-2-0-database?_external=True. Accessed 7 Jun 2023.

Krieger N, Chen JT, Waterman PD. Using the methods of the Public Health Disparities Geocoding Project to monitor COVID-19 inequities and guide action for social justice. https://www.hsph.harvard.edu/thegeocodingproject/covid-19-resources/. Accessed 17 Jun 2023.

Philadelphia police department. Crime Maps and Stats. https://www.phillypolice.com/crime-maps-stats. Accessed 7 Jun 2022.

United States Environmental Protection Agency. EnviroAtlas project. https://www.epa.gov/enviroatlas. Accessed 8 Jun 2022.

Tsai WL, Nash MS, Rosenbaum DJ, Prince SE, DAloisio AA, Neale AC, et al. Types and spatial contexts of neighborhood greenery matter in associations with weight status in women across 28 U.S. communities. Environ Res. 2021;199:111327.

Article CAS PubMed PubMed Central Google Scholar

Knobel P, Kondo M, Maneja R, Zhao Y, Dadvand P, Schinasi LH. Associations of objective and perceived greenness measures with cardiovascular risk factors in Philadelphia, PA: a spatial analysis. Environ Res. 2021;197:110990. https://doi.org/10.1016/J.ENVRES.2021.110990.

Singleton CR, Winata F, Parab KV, Adeyemi OS, Aguiaga S. Violent crime, physical inactivity, and obesity: examining spatial relationships by racial/ethnic composition of community residents. J Urban Health. 2023;100:27989.

Article PubMed PubMed Central Google Scholar

United States Environmental Protection Agency. Smart Location Mapping: National Walkability Index. https://www.epa.gov/smartgrowth/smart-location-mapping#walkability. Accessed 8 Jun 2022.

Parks & Recreation Program Sites OpenDataPhilly. https://opendataphilly.org/datasets/parks-recreation-program-sites/. Accessed 5 Jul 2023.

National Center for Chronic Disease Prevention and Health Promotion (U.S. Division of Nutrition, Physical Activity, and Obesity. Census tract level state maps of the modified food environment index (mRFEI). https://www.cdc.gov/obesity/downloads/census-tract-level-state-maps-mrfei_TAG508.pdf. Accessed 7 Jun 2022.

Esri Consumer Spending: Esri Methodology Statement, June 2021. https://storymaps.arcgis.com/stories/ba42e0b000d0430faf8764931fc7e75e. Accessed 7 Jun 2022.

Cohen DA, Finch BK, Bower A, Sastry N. Collective efficacy and obesity: the potential influence of social factors on health. Soc Sci Med. 2006;62:76978.

Article PubMed Google Scholar

Hutchinson RN, Putt MA, Dean LT, Long JA, Montagnet CA, Armstrong K. Neighborhood racial composition, social capital and black all-cause mortality in Philadelphia. Soc Sci Med. 2009;68:185965.

Article PubMed PubMed Central Google Scholar

Mayne SL, Hannan C, Difiore G, Virudachalam S, Glanz K, Fiks AG. Associations of neighborhood safety and collective efficacy with dietary intake among preschool-aged children and mothers. Child Obes. 2022;18:12031.

Article PubMed Google Scholar

Public Health Management Corporation. Southeastern Pennsylvania Household Health Survey. https://research.phmc.org/52-project-spotlight/248-southeastern-pennsylvania-household-health-survey. Accessed 8 Jun 2022.

Mayne SL, Kelleher S, Hannan C, Kelly MK, Powell M, Dalembert G, et al. Neighborhood greenspace and changes in pediatric obesity during COVID-19. Am J Prev Med. 2023;64:33.

Article PubMed Google Scholar

Child ST, Kaczynski AT, Walsemann KM, Fleischer N, McLain A, Moore S. Socioeconomic differences in access to neighborhood and network social capital and associations with body mass index among black Americans. Am J Health Promot. 2020;34:15060.

Article PubMed Google Scholar

Sampson RJ, Raudenbush SW, Earls F. Neighborhoods and violent crime: a multilevel study of collective efficacy. Science. 1997;277:91824.

Article CAS PubMed Google Scholar

Veenstra G. Social capital, SES and health: an individual-level analysis. Soc Sci Med. 2000;50:61929.

Article CAS PubMed Google Scholar

Halbert CH, Bellamy S, Briggs V, Bowman M, Delmoor E, Kumanyika S, et al. Collective efficacy and obesity-related health behaviors in a community sample of African Americans. J Community Health. 2014;39:12431.

Article PubMed PubMed Central Google Scholar

Dulin A, Risica PM, Mello J, Ahmed R, Carey KB, Cardel M, et al. Examining neighborhood and interpersonal norms and social support on fruit and vegetable intake in low-income communities. BMC Public Health. 2018;18:455. https://doi.org/10.1186/S12889-018-5356-2.

Kawachi I. Social capital and community effects on population and individual health. Ann N Y Acad Sci. 1999;896:12030.

Article CAS PubMed Google Scholar

Read the rest here:

Pediatric obesity during COVID-19: the role of neighborhood social vulnerability and collective efficacy | International ... - Nature.com

Pediatrics

Pediatric Drugs Market Size Expected to Reach USD 363.86 Billion by 2032 – GlobeNewswire

Ottawa, Dec. 21, 2023 (GLOBE NEWSWIRE) -- The global pediatric drugs market size accounted for USD 129.13 billion in 2023 and grew to USD 144.36 billion in 2024, expanding at a healthy CAGR of 12.2% between 2023 and 2032.

In March 2023, WHO released the first list of priority pediatric antibiotic compositions, enabling more concentrated research and development activities that tackle the specific requirements of infants and children.

Pharmaceutical companies are now working more on making medicines specifically for pediatrics, considering age, weight, and how their bodies develop. This is because children have unique traits that can affect how medicines work for them. The market for these pediatric drugs is growing because more kids are getting sick, and there are better ways to design drugs. But there are challenges, like figuring out the right amount of medicine for different ages and dealing with smaller groups of patients, which can make the drugs more expensive. Organizations like the European Medical Agency (EMA) and the Food and Drug Administration (FDA) are making rules to encourage research and ensure that medicines for children are safe and work well.

The market for pediatric drugs is growing because kids often face health issues like stomach, allergy, and respiratory problems due to their weaker immune systems. This market includes drugs for conditions like breathing disorders, autoimmune diseases, stomach issues, heart-related problems, and others. Medicines can be taken orally, applied on the skin, injected, or through other ways. This market spans North America, Europe, Asia-Pacific, the Middle East, Africa, and Latin America, with specific data for 17 countries.

Download a short version of this report https://www.towardshealthcare.com/personalized-scope/5074

Individuals aged 2 to 12 receive pharmaceutical interventions specifically designed for pediatric use. The approach to pediatric therapy is fundamentally different from that of adults, primarily stemming from the imperative to tailor dosage regimens to the unique requirements of pediatric patients. Additionally, differentiation is imperative because the physiological response of a child to a given drug may diverge significantly from that observed in an adult population. Thus, the distinct nature of pediatric therapy is essential for ensuring optimal efficacy and safety in this specific age group. Furthermore, the market experiences a positive impetus due to the expanding landscape of clinical trials aimed at introducing novel pediatric pharmaceutical products. This multifaceted synergy of elements substantiates the robust growth trajectory observed in the pediatric drugs market.

The following factors propel the pediatric drugs market growth

Innovation in Pediatric Drugs Expands Market Growth

The expansion of the pediatric drugs market is driven by several factors, such as advancements in pediatric research, the broadening range of clinical trials, and increased investment in developing medications personalised for children. This trend creates substantial business prospects for pharmaceutical and biotechnology companies specialising in pediatric drug formulations. For instance, in August 2023,Aurobindo Pharma Ltd announced the release of their HIV triple combination medicine to pediatric patients in around 123 low- and middle-income countries.

Additionally, companies offering contract manufacturing services for pediatric pharmaceuticals stand to benefit. Collaborative research ventures, innovative drug delivery methods, and strategic partnerships with healthcare providers further facilitate market growth. Overall, these developments present promising opportunities for growth in the pediatric drugs market.

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

Some of the Recent Pediatric Oncology Drug Approvals by FDA:

Specialised Pharmaceutical Drugs is the Driving Force behind the Growth of the Pediatric Drugs Market

The wider utilization of off-label drugs in the pediatric population underscores the need for specialised pharmaceuticals customised to pediatric drug requirements, fueling innovation and expansion in the pediatric drug market. The expansion of the pediatric drug market is primarily driven by the increasing prevalence of health issues in children, including obesity, diabetes, asthma, and neurological disorders.

This has led to a rising demand for specialised pharmaceuticals personalised to the unique needs of the pediatric population. Recognising children's distinct physiological and developmental characteristics, the pharmaceutical industry increasingly focuses on research and developing drugs specifically designed for them.

The heightened awareness among parents, caregivers, and healthcare practitioners regarding the importance of addressing children's healthcare needs has fueled the demand for pediatric medications. This advocacy has prompted governments and regulatory bodies to introduce incentives, such as market exclusivity and extended patent protection for pediatric drugs, encouraging research in this field. Consequently, these initiatives have attracted pharmaceutical investments and fostered innovation. The surge in pediatric health issues is propelling the growth of the pediatric drug market, underscoring its crucial role in safeguarding and improving the well-being of children globally.

Respiratory Disorders Dominate Pediatric Drugs Market

The pediatric drugs market is anticipated to be predominantly influenced by the respiratory disorder drugs segment, which holds the largest market share. This is primarily attributed to factors such as compromised immunity, heightened pollution levels, and increased exposure to various allergens, leading to chronic respiratory disorders like Chronic Obstructive Pulmonary Disease (COPD). COPD, a significant contributor to the global pediatric healthcare burden, has seen a surge in demand for effective treatments. According to the World Health Organization (2021),COPD ranked as the third leading cause of global mortality in 2019, causing 3.23 million deaths.

The segments growth is driven by the escalating prevalence of rare autoimmune disorders linked to various cancers, genetic disorders, and other autoimmune conditions. The market is further propelled by initiatives to develop drugs for rare diseases, exemplified by the FDA's approval of RUZURGI (amifampridine) tablets from Jacobus Pharmaceutical Company in May 2019. These prescription drugs, though associated with high costs, are contributing to the rapid growth of the global pediatric drugs market.

Customize this study as per your requirement @ https://www.towardshealthcare.com/customization/5074

Rising Prevalence of Diseases in the Pediatric Population Expands the Pediatric Drugs Market Growth

The variance between the high rate of childhood illness, roughly 60%, and the narrow focus of pharmacological trials, about 12%, highlights the unrealized potential in the pediatric medication market. This disparity, coupled with a greater understanding of the particular healthcare requirements of children, has spurred more focus and funding for pediatric medication research. The growth of the pediatric medication business has also been aided by regulatory incentives, including pediatric exclusivity and an understanding of the moral need to address children's health. As a result, pharmaceutical companies are working harder on research and development projects to close this gap and satisfy the unique therapeutic needs of the diseases. They are mostly prevalent with childhood cancer in North America.

According to the Nationwide Childrens Hospitals May 2023 estimates,in the U.S., around 90% of 17,000 paediatrics are diagnosed with cancer every year. 1,000+ Medical research grants at 150 institutions, 240+ Ongoing clinical trials funded each year. The increasing incidence of chronic disorders, encompassing conditions such as anorexia, asthma, congenital disabilities, growth deficiencies, diabetes, childhood cancer, juvenile diabetes, and attention deficit hyperactivity, is projected to positively impact the growth trajectory of the market. This surge in chronic disorders is a primary factor contributing to heightened demand for pediatric drugs, consequently influencing the market dynamics throughout the forecast period from 2022 to 2032.

Obesity is one of the most prevalent conditions among children. For instance, according to data from the 2020-2021 National Survey of Children's Health (NSCH),17% of children aged 10 to 17 in the United States are obese. Obesity is a major problem that leads to several diseases like Type 2 Diabetes, Hypertension, Hyperlipidemia, Liver and kidney diseases, Hypertension, Cancer Risk and others.

Advancement in Healthcare Infrastructure Foster the Pediatric Drugs Market Growth

The escalation of healthcare investment plays a pivotal role in shaping the trajectory of the pediatric drug market. A substantial determinant contributing to market growth is the surge in healthcare expenditure, facilitating the enhancement of healthcare infrastructure. Notably, government bodies are proactively augmenting this development by allocating increased funding to bolster healthcare facilities, exerting a profound impact on market dynamics.

Moreover, the concerted efforts of both public and private entities to raise awareness, coupled with a notable uptick in childhood obesity cases, are poised to further propel the pediatric drugs market. This phenomenon is further accentuated by evolving lifestyle patterns and a burgeoning population, collectively fostering the expansive growth of the pediatric drugs sector. The convergence of these factors delineates a landscape where healthcare investments, governmental initiatives, and societal changes converge to drive advancements in pediatric pharmaceuticals.

Challenges Posed by Limited Market Exclusivity in Pediatric Drug Development

The abbreviated duration of market exclusivity poses a significant obstacle to the growth of the pediatric drugs market. In contrast to pharmaceuticals customised for adults, pediatric medications often face shorter market exclusivity and patent protection periods. This diminishes the financial allure for pharmaceutical companies to invest in pediatric drug development, as they are inclined towards markets where research and development investments can be recouped with substantial profits. The pediatric sector encounters challenges due to smaller patient populations and limited exclusivity periods, making it more difficult to justify allocating resources for research and development. This limitation mainly affects the development of drugs for rare pediatric diseases, where patient numbers are exceptionally restricted.

Consequently, a considerable number of children resort to off-label use of medications intended for adults, posing potential risks to safety and effectiveness. Addressing this constraint necessitates policy and regulatory reforms that offer enhanced incentives for pediatric drug development, ensuring children can access secure and efficacious treatments.

Drug Type Segment Holds a Substantial Market Share

The paediatrics drugs market is categorized by type, encompassing analgesic and antipyretic, central nervous system drugs, especially antibiotics, gastrointestinal drugs, respiratory drugs, and vaccines. The segment held a significant market share, driven by children's lower immunity, increasing pollution, and allergen exposure leading to chronic respiratory disorders, including Chronic obstructive pulmonary disease. Montelukast is notably employed for asthma prevention in children 2 years and older, particularly for exercise-induced bronchoconstriction. The Autoimmune Disorders segment is anticipated to exhibit substantial growth, attributed to the rising incidence of genetic disorders, cancers, and cystic fibrosis. In addition, mental health problems sucg as anxiety, depression, ADHD, and behavioural problems are also common among children aged 5-27 years.

Fig. Percentage of Children and Adolescents Aged 5-17 Years Who Received Mental Health Medication Counselling or Therapy from a Mental Health Professional Between 2019 and 2022 in the U.S.

Additionally, the Pediatrics Medicine Market growth is further fueled by the inclusion of antibiotics, analgesics, antipyretics, respiratory drugs, gastrointestinal drugs, central nervous system drugs, vaccines, and others in the pediatric disease treatment spectrum. This comprehensive range contributes significantly to the overall market expansion.

The Route of Administration Segment brings Substantial Growth in the Pediatric Drugs Market

The Pediatrics Medicine Market is categorized based on the route of administration, namely topical, oral, parental, and others. In 2020, the Oral segment dominated with the highest revenue share. This is attributed to the preference for non-invasive oral delivery in pediatric patients, minimizing pain and enhancing parental comfort, resulting in improved medication compliance.

This growth is driven by the minimal risk of adverse reactions and drug interactions, along with the ease of administration to children. Additionally, factors such as cost-effectiveness, lower drug quantities, and the concentrated application of antibiotics in affected areas contribute to the growth of this route of administration.

The Distribution Channel Segment expands the Pediatric Drugs Market Growth

Browse More Insights of Towards Healthcare:

Geographical Landscape:

North America dominates the pediatric drugs market due to rising healthcare spending, supportive regulatory framework, and quick adoption of advanced technologies across the U.S. and Canada. The growth in this region is primarily attributed to its robust healthcare infrastructure, substantial research and development capabilities, and a significant pediatric patient demographic. The region's dominance is further bolstered by favourable regulatory frameworks and government incentives, fostering the development and accessibility of pediatric medications. For instance, in 2021, US FDA approved the Rethymic drug for pediatric patients and used it to treat rare immune disorders. Rethymic is the 1st thymus tissue that is approved in the United States.

The market benefits from North America's dedicated focus on pediatric healthcare heightened awareness among parents and healthcare professionals, and the region's economic strength. Additionally, the presence of leading pharmaceutical companies further solidifies North America's prominent position in the global pediatric drugs market. During the forecast period, the Asia-Pacific region is poised for significant pediatric drug market growth. This expansion is driven by various vital factors, including the region's substantial and expanding pediatric population, leading to an increased demand for specialized healthcare solutions for children. The economic prosperity and expanding middle-class demographic in Asia-Pacific also enhance affordability and accessibility to pediatric medications.

Government initiatives and increased regional healthcare investments are pivotal in fostering market growth. The pharmaceutical industry in Asia-Pacific is channelling more resources towards developing medications tailored for pediatric patients. This concerted effort has positioned the region as a significant influencer in the pediatric drugs market, emerging as a central hub for research, development, and distribution of pharmaceuticals for children.

Competitive Landscape

The pediatric drugs are competitive, with a few big companies leading the way. Some of these companies have a larger share of the market. To stay ahead, some introduce new medicines to tackle existing problems, while others ensure they reach the people needing them.

In the past 10 years, pharmaceutical companies have increasingly chosen external organisations known as CROs, i.e. Contract Research Organisations, for their clinical trial and clinical research. A Tufts University and ICON PLC study predicts that by 2022, about 72% of global clinical trials will be handled by CROs. The combination of research and accessibility strategy allows these companies to stay ahead in the competitive landscape of pediatric medication.

Key Market Players:

Pediatric Drugs Market Segmentation:

By Drug Type:

By Route of Administration:

By Distribution Channel

By Geography

Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

About Us

Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.

Web: https://www.towardshealthcare.com

Browse our Brand-New Journal@ https://www.towardspackaging.com

Browse our Consulting Website@ https://www.precedenceresearch.com

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare

Continue reading here:

Pediatric Drugs Market Size Expected to Reach USD 363.86 Billion by 2032 - GlobeNewswire

Pediatrics

Maternal Flu Shot Protects Infants Against Severe Disease – Medpage Today

Maternal influenza vaccination was effective at protecting infants under 6 months against severe disease, a case-control study showed.

While overall effectiveness was 34% (95% CI 12-50) against markers of severe disease -- hospitalizations and emergency department (ED) visits combined -- effectiveness was significant for hospitalizations (39%, 95% CI 12-58) but not for ED visits in secondary analyses, according to Leila Sahni, PhD, MPH, of Baylor College of Medicine and Texas Children's Hospital in Houston, and colleagues.

Effectiveness was also greater for infants less than 3 months of age (53%, 95% CI 30-68) and when mom was vaccinated during the third trimester (52%, 95% CI 30-68), they reported in JAMA Pediatrics, though they noted that secondary analyses should be considered exploratory.

"Infants younger than 6 months are at high risk of influenza-associated complications but are not eligible for vaccination given the absence of licensed influenza vaccines for this age group," Sahni and colleagues wrote. "Maternal influenza vaccination is safe, immunogenic, and can prevent laboratory-confirmed influenza and its complications in both mothers and infants."

However, "recent evidence, particularly from the U.S. after the H1N1 pandemic and data on maternal effectiveness by timing during pregnancy are limited," they added. "Updated data are needed on maternal vaccine effectiveness and data to determine optimal timing of vaccination to benefit the pregnant person and their infant."

Further results from secondary analyses showed that effectiveness of maternal influenza vaccination wasn't significant when mothers were vaccinated during their first or second trimesters.

"These findings, particularly the timing of maternal vaccination, weren't surprising to us," Sahni told MedPage Today in an email. "However, this speaks to the complexity of maternal vaccination timing, and the need to balance benefit to the mother who should ideally be vaccinated before influenza season begins, which may occur early in pregnancy, against benefit to the infant, which we found was greatest when vaccination occurs later in pregnancy."

"Additional studies should investigate the timing of vaccination during pregnancy and the benefit to the mother and infant," Sahni added.

Vaccine effectiveness was 47% against influenza B (95% CI 13-68) but it wasn't significant against influenza A, the researchers found; nor was it effective against influenza A subtypes H1N1 or H3N2 in those secondary endpoint analyses.

Sensitivity analyses excluding infants with positive test results for A/H3N2 and mothers with prior season vaccination yielded vaccine effectiveness of 43% (95% CI 17-60) and 42% (95% CI 20-58), respectively, the researchers added.

The study "strengthens the evidence that infants benefit when persons receive the quadrivalent-inactivated influenza vaccine during pregnancy," Katherine Poehling, MD, MPH, of Atrium Health Wake Forest Baptist, in Winston-Salem, North Carolina, and colleagues wrote in an accompanying editorial, noting that guidelines from the CDC and the American College of Obstetricians and Gynecologists recommend that pregnant patients receive the inactivated influenza vaccination during the flu season. "With only half of pregnant persons receiving the influenza vaccine in this study and nationally, there is a huge opportunity to improve vaccine coverage and health outcomes for all pregnant persons and newborns."

Opportunities to optimize the health of mothers and their babies include expanding vaccine registries from children to persons of all ages, having all clinicians who see pregnant persons strongly recommend flu vaccination during pregnancy, and having obstetric and pediatric clinicians collaborate on approaches to improve access to, confidence in, and coverage of vaccines and preventive care, they added.

"These data are very encouraging and provide us with updated evidence supporting the benefit of influenza vaccination during pregnancy to protect both the pregnant person and their infant from serious influenza illness," Samantha Olson, MPH, co-first author of the study and epidemiologist with the CDC's Influenza Division, told MedPage Today in an email.

For this prospective, test-negative case-control study, Sahni and colleagues used data from the CDC's New Vaccine Surveillance Network from the 2016/2017 through the 2019/2020 influenza seasons. Infants younger than 6 months of age with an ED visit or hospitalization for acute respiratory illness were included from seven pediatric medical centers in the U.S. Infants with an influenza-negative molecular test were included as controls.

Among 3,764 infants included in the study, 53% were born to vaccinated mothers, including 94 of 223 (42%) infants with influenza and 1,913 of 3,541 (54%) control infants. Among the 2,007 vaccinated mothers, 54% had vaccination verified by immunization information systems or medical records and 46% had self-reported vaccination with timing.

Study limitations included that information about maternal influenza infection during or after pregnancy was not included, nor were data on influenza vaccination prior to conception or postpartum.

Jennifer Henderson joined MedPage Today as an enterprise and investigative writer in Jan. 2021. She has covered the healthcare industry in NYC, life sciences and the business of law, among other areas.

Disclosures

The study was supported in part by the CDC.

Authors reported relationships with the NIH, Sanofi, Quidel, Merck, AstraZeneca, Pfizer, GSK, Cepheid, Viracor, AbbVie, Ark Biopharma, Meissa, Moderna, and Shionogi.

Editorialists reported relationships with Optum, Organon Nexplanon, and DynaMed EBSCO Industries.

Primary Source

JAMA Pediatrics

Source Reference: Sahni LC, et al "Maternal vaccine effectiveness against influenza-associated hospitalizations and emergency department visits in infants" JAMA Pediatr 2023; DOI: 10.1001/jamapediatrics.2023.5639.

Secondary Source

JAMA Pediatrics

Source Reference: Zuber MJ, et al "Influenza vaccination in pregnancy -- rolling up sleeves for pregnant persons and infants" JAMA Pediatr 2023; DOI: 10.1001/jamapediatrics.2023.5630.

Continued here:

Maternal Flu Shot Protects Infants Against Severe Disease - Medpage Today

Pediatrics

Missouri pediatricians provide holiday tips for families and children – Kirksville Daily Express and Daily News

Missouri American Academy of Pediatrics

The Missouri Chapter, American Academy of Pediatrics (MOAAP) is offering tips and resources on how families can remain safe this joyous holiday season.

The holidays can be really overwhelming when kids get off their routines and their schedules. It can make them feel a little anxious, said Dr. Maya Moody, MOAAP president. It's important to make sure that you keep mealtimes and bedtimes the same, to the extent you can, for both little kids and teenagers too. Sleep is really important for mental health, and so is making sure kids have those routines, their general schedule, and they know what to expect.

To help families keep holiday spirits high while avoiding ill-timed emergencies, the American Academy of Pediatrics (AAP) offers these 12 health and safety tips:

Stick to your child's usual sleep and mealtime schedules when you can. It's not always possible when you are juggling the demands of shopping, cooking and travel, but maintaining household routines will help ward off tantrums and maintain holiday cheer.

Take care of yourself, mentally and physically. Children sense the emotional wellbeing of their parents and caregivers, and if you cope with stress successfully, your children will learn how to do the same.

Don't feel pressured to overspend on gifts. Consider helping your child make one or two gifts. The chances are these will be the gifts most treasured by a parent, grandparent or special adult.

Participate in a volunteer activity and include your child, whether it's helping serve a holiday meal at a local food bank or shelter or writing letters to members of the armed forces who can't be home for the holidays.

Toys don't need to be expensive or electronic to make great gifts, but they should be suited to the child's age, abilities, skills and interest level. Be cautious about toys that contain button batteries or magnets, which can be swallowed by small children and cause serious internal damage. For more help with toy safety, go here.

Speaking of toys, if you are considering a digital device for a child or a teen, such as a tablet, smartphone or game system, think about the purpose of the device and the rules you want to set around its use. AAP offers a family media planning tool here.

Cooking with children can be a great way to bond over a family recipe and offer a sense of accomplishment to budding chefs. Be sure to follow food safety guidelines, wash hands frequently and keep hot foods and liquids away from the counter's edge. More kitchen safety tips are here.

When decorating, watch for fire hazards. If you have an artificial tree, make sure it's labeled "Fire Resistant," and if it's live, make sure it's fresh and not losing too many needles. Keep it away from fireplaces, radiators or portable heaters.

Keep trimmings with small removable parts out of reach of children to prevent them from swallowing or inhaling pieces. Find more tips on decorating safely here.

When visiting friends or family, remember that the homes you visit may not be childproofed. Keep an eye out for danger spots like unlocked cabinets, unattended purses, accessible cleaning or laundry products, stairways, or hot radiators. When visiting others or hosting guests, make sure that any medications are stored safely away from curious kids. Pay special attention to narcotics and other prescription medications.

After a holiday party, clean up immediately. A toddler could rise early and choke on leftover food or come into contact with alcohol, tobacco or vaping products.

Most important of all, enjoy the holidays for what they are- time to enjoy your family. Find ways to spend time together, whether it's on a sled outdoors or over a board game or good picture book.

We hope these tips help remove some stress for caregivers and help families remain safe and healthy this holiday season, said Dr. Heidi Sallee, MOAAP Vice President/President-Elect. Parents and caregivers need to take care of themselves and ensure our own emotional well-being as well because kids pick up on that.

The Missouri Chapter, American Academy of Pediatrics (MOAAP) represents more than 1,100 physicians, trainees, and pediatric-provider members throughout Missouri. Our mission is to promote the health of all Missouris children through advocacy, education, and collaboration. For more information, visit missouriaap.org.

See more here:

Missouri pediatricians provide holiday tips for families and children - Kirksville Daily Express and Daily News

Pediatrics

Brief Training Improves Counseling by Pediatricians on Social Media Safety – Physician’s Weekly

Training on social media safety for pediatricians improved rates of patient counseling on the topic and adolescents social media behavior.

This study arose, in part, from an enthusiasm among pediatricians wanting to understand how they could best support families in navigating social media for their kids, Megan Moreno, MD, MSEd, MPH, explains. We know that pediatricians can serve as a trusted source of information for families, and this study reflects that.

Dr. Moreno and colleagues tested a social media counseling intervention aimed at promoting safe social media use among youth through a randomized controlled trial. The researchers enrolled pediatric primary care practices between 2011 and 2013 and recruited youth participants during clinical visits. Study outcomes included media behaviors and caregiver communication. Multivariate regression models assessed associations between social media counseling and the pediatricians counseling score, and multivariate logistic regression evaluated four social media behavior outcomes.

This study was done as a randomized controlled trial, which can provide the very best level of evidence that an intervention does or does not work, and was conducted with pediatricians in their officesso it was as close to a real-world setting as possible, Dr. Moreno notes.

The study, published in The Journal of Adolescent Health, included 249 pediatricians representing 120 practices. More than half (53%) were independent pediatric group practices, and more practices were in suburban communities (46%) versus rural (19%), non-inner city urban (19%), and inner-city urban (16%) settings. Dr. Moreno and colleagues randomly assigned 58 practices to the social media intervention arm.

Could a brief training in social media lead to changes in how pediatricians counsel their patients? We found that the answer is YES! Dr. Moreno says. Training pediatricians in social media safety led to pediatricians consistently providing this counseling.

The greatest predictor of a clinician providing social media counseling was being trained on such counseling (adjusted OR, 4.94; 95% CI, 3.83-6.37), Dr. Moreno says (Table).

This may feel like an of course moment, she continues. However, when we were planning this intervention, we heard concerns from pediatricians that there could be generational barriers to learning this content or feeling comfortable providing counseling on this topic. There were no demographic differences among pediatricians willing to provide this counseling, and if they had training, they would provide the counseling, put those concerns to rest.

The researchers also reported positive findings for adolescent patients who received social media counseling from their pediatricians.

The intervention had a positive impact on reducing teens friending of strangers on social media and on teens communicating with their parents about social media, Dr. Moreno says. We did not find an impact on screen time, but, in recent years, the field has moved away from screen time as an accurate or meaningful measure of social media safety.

According to the study results, after 6 months, teens could recall receiving social media counseling, which aligns with previous findings that adolescents can accurately recall counseling from a clinician. Dr. Moreno and colleagues wrote that the counseling provided in the current study may have been more memorable given the relevance and significance of social media to youth.

The results underscore the role that pediatricians have in helping families navigate the use of media safely, says Dr. Moreno, who also serves as co-medical director of the Center of Excellence on Social Media and Youth Mental Health from the American Academy of Pediatrics. The organization is dedicated to creating a healthy digital ecosystem for children and adolescents, according to its website. Dr. Moreno notes that efforts are underway to expand the training opportunities for pediatricians to be part of this work.

Looking ahead to future studies, Dr. Moreno says research is needed to assess ways to incorporate specific tools, such as the Family Media Plan from the American Academy of Pediatrics, into the counseling that pediatricians provide families to see if this increases uptake and use of this family-centered tool.

More:

Brief Training Improves Counseling by Pediatricians on Social Media Safety - Physician's Weekly

Pediatrics

Amateur Spotlight: Retired Pediatrician Gives Back And Pushes Forward – The Chronicle of the Horse

In the late 1990s, Angela Millon was a busy pediatrician. Shed worked hard to get where she was, giving up horses for college, working her way through medical school and residency, and starting a family with her husband, John Millon.

But after 20 years out of the saddle, the horses came calling when she and her family moved to Greenville, South Carolina, for her job.

Angela jumped back wholeheartedly, buying a small farm and a horse, and her children, Meagan and Michael Millon, soon caught the horse bug. The trio competed locally and on the A circuit until the children went off to college.

In 2015, Angela had another revelation and realized that in her mid-50s, she still had plenty of lofty riding goals she wanted to achieve. With Johns encouragement, she retired and put all her energy into qualifying for her bucket-list horse shows, like Devon (Pennsylvania) and the indoor circuit.

All of a sudden one day I said, Im not going to be able to do this at this level forever, and Im not getting any younger, she said. I want to go to Devon, I want to qualify for indoor finals; I need to have time to dedicate to that, and working full time, theres just not enough hours in the day. I didnt have enough time to go to as many horse shows as I needed to go to, to get it done. The kids were in college, and I just cut back a little for a year or two, then finally my husband said, Just retire. Go for it.

And she did, making it to Devon, the Pennsylvania National and the National Horse Show (Kentucky) in 2016 in the amateur-owner hunters with Motown, a Hanoverian gelding (Don PrincipeEM Rising Star).

I did get ribbons, not the primary colors, but I did. Those were on my bucket list, to be able to go and do that, she said.

During her retirement, Angela became involved in the local Tryon Riding & Hunt Club in nearby Tryon, North Carolina. The organization, founded in 1925, put on rated and local shows, where Angela and her children were regulars over the years.

Those shows were very special, she recalled. They were very different from the rest of the little local circuit shows. They had such a rich history and tradition, and the exhibitor parties were amazing. The board members would descend on the show grounds, and there this little, small town warmth. Theyd come around and bring drinks and snacks. It was just wonderful. The kids and I looked forward to those shows.

As she got to know more people involved with TRHC, she was asked to join their board of directors. She is now heading into her seventh year as a member and third year as president.

TRHC now supports a steeplechase, horse and hound show, rated hunter/jumper shows, dog shows, horse trials and two charity horse shows.

Theres a lot of really rich, traditional activities that have been on the social calendar in Tryon for decades, Angela said. I love giving back to the community. Over the last five years, TRHC has given $200,000 back to the community and about half of that goes to horse-related places. The worlds been good to me. I like giving back.

For her volunteer work with TRHC and for her work asa founding member and co-chair of the Carolinas Show Hunter Hall of Fame, which honors horses and horsemen tied to the Carolinas, Angela received the U.S. Hunter Jumper Associations Amateur Sportsmanship Award at the organizations annual meeting, held Dec. 4-7 in Concord, North Carolina.

I was so humbled and surprised, she said. You sort of just do what you do and dont think much about it. A lot of people know who I am in Tryon, North Carolina, but on a national scale, to get national recognition, that was huge. Going to that meeting and listening to the lifetime achievement presentation and the visionary presentation, it was so inspiring and sort of gave me a kick in the pants, like, Alright, youve got one more year as the president of TRHC. Youve done a whole lot, youve done well, but dont coast your last year. Dig in and keep going because you can always do what youre doing a little bit better.

Finding A Path

Born in Charleston, South Carolina, Angela was always horse crazy. When her family moved to Connecticut, she started riding with Show Hunter Hall of Fame inductee Rick Fancher. All students had to care for their own horses, so Angela got an education in horsemanship.

He had a great system, she said. If you could clip the school horses and do a great job, then you could clip your own. Of course, it was like Huck Finn! I was like, OK, great! I learned how to clip and bandage and take care of horses from the get-go.

She was a member of the local Pony Club in Weston, Connecticut, and a trip to the National Horse Show helped inspire her interest in medicine.

One of our field trips was to go to the old National Horse Show at Madison Square Garden. A lot of the horses that came into the ring, they would say, Dr. and Mrs. this or Mrs. that, and I was like, Huh, maybe if I grow up and become a doctor, Ill have enough money to have horses, she recalled with a laugh.

Of course, it wasntjustthat which got her through medical school and a residency.

Ive always liked taking care of things, she said. I thought I wanted to be a vet, but I went out with a vet in Connecticut and made rounds with him, and it just so happened that the day or two that I went out with him, I got drug, trampled, stamped, and I was like, I dont know if I can survive being a vet. I always knew I wanted to do something medical, so I ended up doing people medicine instead of horse medicine.

I love taking care of kids and familiesthe continuity of it, she said. You take care of a kid from birth until they go off to high school or college. You get to really know the whole family. It was great. I loved it.

When she got back into riding, Angela kept the familys horses at home and taught her children the importance of horsemanship.

I didnt want to just take a riding lesson once a week. I wanted to have a horse and do it like I did as a kid, she said. I didnt realize what I was setting myself up for, because it was three times the work and expenses, but both my kids rode all the way through high school;my daughter rode through college. We had so much fun doing it together. We were like partners in crime. Those were wonderful days.

Pediatrics and horses are so alike: The little kids cant tell you whats wrong. Youve got to look at them and see the look in their eye and read their non-verbal stuff to know, are they sick or are they well?

After her children went off to collegeand after 25 years of doing the barn work herselfAngela felt lonely riding at home, so she moved her current horse, Jackson Square, to a barn where she could have a sense of camaraderie with other adult amateurs.

To me [horsemanship] is huge. I feel like I know my horses, she said. Pediatrics and horses are so alike: The little kids cant tell you whats wrong. Youve got to look at them and see the look in their eye and read their non-verbal stuff to know, are they sick or are they well? They cant tell you what hurts. I think theres a big crossover when youre looking at a horse. You walk in the stall, glance in, and I can tell you, is he OK or not? Its because youre with them every single day and you know 100 percent what is there normal and what isnt. I think a lot of amateurs dont have that experience because they dont take care of their horses on a daily basis. I think its very important.

Angela rides with Gisele Beardsley OGrady at Clear View Farm in Landrum, South Carolina. She shows Jackson, an 11-year-old Dutch Warmblood gelding (Q Breitling LSUrrike) in the amateur-owner hunters, and OGrady shows him in the 36 performance hunters.

I decided, Im young enough, I can do this, lets move on and try one more time, Millon said. Hes probably the best jumping horse Ive ever owned, but they all come along at different speeds, and hes been slow to mature.

At age 60, Angela still wants to get back to Devon and the fall indoor shows, and possibly earn primary-color ribbons there.

But shes not solely focused on the show ring: Returning to her childhood days in the hunt field, she recently went out for the first time with the Tryon Hounds for fun.

When asked what advice shed give to older adult amateurs, she said, Dont give up. Its out there. Surround yourself with the right village. Make sure youre with the trainer that shares your goals, that supports you. Its a journey. Enjoy every day. Every single day I go to the barn, Im in my happy place, and its just a good day. Especially when I was working, no matter how bad a day I had, as soon as I got to the barn, life was good.

See the original post here:

Amateur Spotlight: Retired Pediatrician Gives Back And Pushes Forward - The Chronicle of the Horse

Pediatrics

Stop Children’s Cancer, Inc. renews $1M gift for pediatric cancer research Giving UF Health University of Florida – UF Health

Stop Childrens Cancer presents a renewed gift of $1 million to support cancer research and clinical trials in the UF College of Medicine division of hematology and oncology.

Continuing their support in the fight against pediatric cancer, Stop Childrens Cancer, Inc. has renewed a $1 million gift to the University of Florida College of Medicine division of pediatric hematology/oncology. This contribution will fuel research innovations in therapies and treatments aimed at improving outcomes for children facing cancer.

One researcher leading the fight is UF Health pediatric oncologist Elias Sayour M.D., Ph.D., holder of the Stop Childrens Cancer/Bonnie R. Freeman Professorship for Pediatric Oncology Research chair. Sayour and his team are investigating new nanotechnology vaccines to reprogram the immune system against cancer cells. Their focus is on personalized nanoparticles, designed to educate the immune system to reject pediatric cancer and presents a transformative approach to the fight against this disease. Their work, alongside other pioneering efforts, highlights the cutting-edge advancements taking place at UF.

In the field of pediatric immunotherapy, meaningful progress has been made with new agents like CAR T-cells and rituximab, a type of antibody therapy that can be used alone or with chemotherapy, said Dr. Sayour. UF provides a unique opportunity to develop and trial these agents individually and in combinations.

Cancer is the number one cause of death by disease in children in the United States. Sayour added that the work that is discovered and developed at UF is helping to treat children with pediatric cancer across the world.

Stop Childrens Cancer is a local nonprofit organization committed to the prevention, control and cure of childhood cancers. The organization was founded in 1981 by Bonnie R. Freeman, her parents Howard and Laurel, and her sister Carolyne. Bonnie told her family that her goal was to raise $1 million to fight childhood cancers, so that other children and families wouldnt have to suffer.

With this continued additional gift, our hopes are that more children have the ability to become healthy, Howard Freeman said.

When Bonnie was diagnosed with leukemia, she had a 35% chance of living for five years. Today, children with that same diagnosis have a 90% cure rate, according to the UF College of Medicine department of pediatrics division of hematology/oncology.

Bonnie inspired us so much the way she understood the reality of where she was at, Laurel Freeman said. She was determined to live every day to the fullest and that really motivated us.

Sadly, Bonnie died in 1983 at age 12.

Bonnies legacy endures through the organizations tireless efforts. In the 42+ year history of Stop Childrens Cancer, over $7 million has been contributed for pediatric cancer research, helping to double the number of physicians in clinical trials and boosting cure rates. As a result of the organizations early donations of seed money to UF, more than $23 million in funding has been secured by doctors and researchers.

Stop Childrens Cancer started as the heartfelt response of a 10-year-old diagnosed with cancer. Its one of the purest, altruistic charities, driven by a dream to spare other families the challenges we faced, Carolyne Freeman said. The culture of giving can be seen throughout every part of Stop Childrens Cancer from the board to our sponsors, to our volunteers. Whether contributing financially or with time, its a meaningful investment and its making an impact in the world. We truly hope childhood cancer becomes a disease of the past.

Make a gift

Your gift will support cancer research and clinical trials in the UF College of Medicine division of hematology and oncology

Link:

Stop Children's Cancer, Inc. renews $1M gift for pediatric cancer research Giving UF Health University of Florida - UF Health

Pediatrics

Contemporary Pediatrics week in review: Nirsevimab recommendation, AAP updates, and more – Contemporary Pediatrics

Image Credit: Contemporary Pediatrics

Thank you for visiting the Contemporary Pediatrics website. Take a look at some of our top stories from last week (Monday, October 23 to Friday, October 27, 2023) and click on each link to read and watch anything you may have missed.

1.) Steven Selbst, MD, discusses ED trends, highlights mental health admissions

While at the 2023 American Academy of Pediatrics National Conference & Exhibition, Steven Selbst, MD, spoke with Contemporary Pediatrics about current trends in pediatric emergency medicine, and highlighted the ongoing mental health crisis.

Click here for the full article.

2.) Delta-8 accessibility to minors online

In recent research highlighted at the 2023 American Academy of Pediatrics National Conference & Exhibition, investigators sought to evaluate the level of access and marketing of Delta-8 THC (D8) to minors online.

Click here for the full article.

3.) Lessons in asking patients' gender identity and sexual orientation

A recent study presented at the 2023 American Academy of Pediatrics National Conference & Exhibition evaluated how clinicians can ask patients' sexual orientation and gender identity for EHR documentation.

Click here for the full article.

4.) Negotiating to get paid what you deserve

Susan J. Kressly, MD, FAAP, shares tips and aspects of her session, "How to Ensure You Will Be Paid What Youre Worth," presented at the 2023 American Academy of Pediatrics National Conference & Exhibition, in this Contemporary Pediatrics interview.

Click here to watch the full interview.

5.) CDC recommends nirsevimab be prioritized for highest-risk infants amid limited availability

The Centers for Disease Control and Prevention is advising providers to prioritize 100 mg doses of nirsevimab, a monoclonal antibody FDA-approved to prevent respiratory syncytial virus (RSV), for infants at the highest risk of severe RSV disease.

Click here for the full article.

For more from Contemporary Pediatrics, click here.

See original here:

Contemporary Pediatrics week in review: Nirsevimab recommendation, AAP updates, and more - Contemporary Pediatrics

Pediatrics

UNE Student Pediatrics Club wins national award for its efforts in the … – University of New England

The University of New England College of Osteopathic Medicine (COM) Pediatrics Club has won a national award for excellence in advocacy and programming during the 2022-2023 school year.

Three club representatives traveled to Washington, D.C. on Oct. 21 to accept the American Academy of Pediatrics (AAP) Section on Pediatric Trainees Pediatric Interest Group of the Year Award at the AAP National Conference and Exhibition.

This award really helps to show that our school has a solid interest in pediatrics, and helps to confirm that, as a club, we are dedicated to providing opportunitiesfor our fellow students to engage at both an academic and community level with pediatric populations, said Casey McAndrews, club president and a student doctor in the Class of 2026.

The Pediatrics Club is a student-run organization for medical students who are interested in a career in pediatrics. Club members volunteer with pediatric initiatives in the local community, raise money for charities, and raise osteopathic student awareness of the field.

The award includes an honorarium to help support future club initiatives, McAndrews noted, like its Wellness Warriors Program, which was suspended at the beginning of the COVID-19 Pandemic. The program brings club volunteers to the Biddeford Intermediate School to teach fourth-grade students about various health topics, ranging from dental and sleep hygiene to the importance of physical activity and good nutrition. McAndrews hopes to restart the program this spring.

The club also hosts fundraisers for the local community, including its annual Alexs Lemonade Stand Bake Sale each September, where the club has raised nearly $2,400 for childhood cancer research over the last two years.

We are so proud of our club's accomplishments and are excited to keep providing a variety of opportunities for our club members to engage in service, advocacy, and education to care for pediatric populations,McAndrews said.

The club is now gearing up for its annual Holiday Giving Tree event with Sigma Sigma Phi, the osteopathic honorary service fraternity at UNE, where members collect gifts to donate to students at JFK Elementary School in Biddeford.

The support of UNE and the local community leaders have been an essential part of the clubs success, McAndrew adds.

We could not have hosted any of our events, volunteering opportunities, or fundraisers without the amazing support from our faculty advisors and the Office of Recruitment, Student, and Alumni Services, McAndrews said.

Read more here:

UNE Student Pediatrics Club wins national award for its efforts in the ... - University of New England